A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants

Gut

Volumn 63, Issue 8, 2014, Pages 1284-1292

  Sylvester, Karl G ^a,b   Ling, Xuefeng B ^b   Liu, G Y ^b,c   Kastenberg, Zachary J ^b   Ji, Jun ^b   Hu, Zhongkai ^b   Peng, Sihua ^b   Lau, Ken ^b   Abdullah, Fizan ^c   Brandt, Mary L ^d   Ehrenkranz, Richard A ^e   Harris, Mary Catherine ^f   Lee, Timothy C ^d   Simpson, Joyce ^e   Bowers, Corinna ^g,h   Moss, R Lawrence ^g,h  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g NATIONWIDE CHILDREN S HOSPITAL   (United States)

^h THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FIBRINOGEN; FIBRINOGEN PEPTIDE FGA1826; FIBRINOGEN PEPTIDE FGA1883; FIBRINOGEN PEPTIDE FGA2659; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

CLINICAL DECISION MAKING; INFLAMMATORY MEDIATORS; PAEDIATRIC GASTROENTEROLOGY; PAEDIATRIC SURGERY; PEPTIDES;

ALGORITHMS; AREA UNDER CURVE; BIOLOGICAL MARKERS; ENTEROCOLITIS, NECROTIZING; FEMALE; FIBRINOGEN; HUMANS; INFANT; MALE; PEPTIDES; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE;

EID: 84904066424     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305130     Document Type: Article

References (38)

1. Guthrie SO, Gordon PV, Thomas V, et al. Necrotizing enterocolitis among neonates in the United States. J Perinatol 2003;23:278-85. (Pubitemid 36764115)
2. Kamitsuka MD, Horton MK, Williams MA. The incidence of necrotizing enterocolitis after introducing standardized feeding schedules for infants between 1250 and 2500 grams and less than 35 weeks of gestation. Pediatrics 2000;105:379-84. (Pubitemid 30078681)
3. Blakely ML, Lally KP, McDonald S, et al. Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: A prospective cohort study by the NICHD Neonatal Research Network. Ann Surg 2005;241:984-9; discussion 9-94.
4. Blakely ML, Tyson JE, Lally KP, et al. Laparotomy versus peritoneal drainage for necrotizing enterocolitis or isolated intestinal perforation in extremely low birth weight infants: outcomes through 18 months adjusted age. Pediatrics 2006;117: 680-7.
5. Moss RL, Kalish LA, Duggan C, et al. Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: A multi-institutional study. J Perinatol 2008;28:665-74.
6. Moss RL KL, Duggan C, Johnston P, et al. Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: A multi-institutional study. J Perinatol 2008;28:665-74.
7. Ling XB, Lau K, Kanegaye JT, et al. A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses. BMC Med 2010;9:130-41.
8. Ling XB, Mellins ED, Sylvester KG, et al. Urine peptidomics for clinical biomarker discovery. Adv Clin Chem 2010;51:181-213.
9. Ling XB, Sigdel TK, Lau K, et al. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol 2010;21:646-53.
10. Tibshirani R, Hastie T, Narasimhan B, et al. Sample classification from protein mass spectrometry, by peak probability contrasts. Bioinformatics 2004;20:3034-44. (Pubitemid 39619195)
11. Yasui Y, Pepe M, Thompson ML, et al. A data- Analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics 2003;4:449-63.
12. Tibshirani R, Hastie T, Narasimhan B, et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002;99:6567-72. (Pubitemid 34526173)
13. Ling XB, Lau K, Deshpande C, et al. Urine peptidomic and targeted plasma protein analyses in the diagnosis and monitoring of systemic juvenile idiopathic arthritis. Clin Proteomics 2010;6:175-93.
14. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21. (Pubitemid 32397092)
15. Sing T, Sander O, Beerenwinkel N, et al. ROCR: visualizing classifier performance in R. Bioinformatics 2005;21:3940-1. (Pubitemid 41535515)
16. Mi H, Lazareva-Ulitsky B, Loo R, et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005;33:284-8.
17. Decramer S, de Peredo AG, Breuil B, et al. Urine in clinical proteomics. Mol Cell Proteomics 2008;7:1850-62.
18. Sigdel T, Ling XB, Lau K, et al. Urinary peptidomic analysis identifies potential biomarkers for acute rejection of renal transplantation. Clin Proteomics 2009;5:103-13.
19. Lin Z, Fitzgerald JB, Xu J, et al. Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res 2008;26:1230-7.
20. Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child 2006;91:847-51. (Pubitemid 44521172)
21. Peng Q, Zhou TF, Chen CH, et al. Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease. Zhonghua Er Ke Za Zhi 2005;43:676-80.
22. Gavin PJ, Crawford SE, Shulman ST, et al. Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol 2003;23:576-81. (Pubitemid 36438068)
23. Chua MS, Sarwal MM. Microarrays: new tools for transplantation research. Pediatr Nephrol 2003;18:319-27. (Pubitemid 36790068)
24. Senzaki H, Masutani S, Kobayashi J, et al. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 2001;104:860-3. (Pubitemid 32778033)
25. Matsuyama T. Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis. Pediatr Int 1999;41:239-45. (Pubitemid 29272384)
26. Herrick S, Blanc-Brude O, Gray A, et al. Fibrinogen. Int J Biochem Cell Biol 1999;31:741-6. (Pubitemid 29333117)
27. Bennett JS. Platelet-fibrinogen interactions. Ann N Y Acad Sci 2001; 936:340-54. (Pubitemid 32613920)
28. Matsuda M, Sugo T. Structure and function of human fibrinogen inferred from dysfibrinogens. Int J Hematol 2002;76(Suppl 1):352-60.
29. Lord ST. Fibrinogen and fibrin: scaffold proteins in hemostasis. Curr Opin Hematol 2007;14:236-41. (Pubitemid 46597609)
30. Young C, Sharma R, Handfield M, et al. Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention? Pediatr Res 2009;65:91R-7R.
31. Rabinowitz SS, Dzakpasu P, Piecuch S, et al. Platelet- Activating factor in infants at risk for necrotizing enterocolitis. J Pediatr 2001;138:81-6. (Pubitemid 32097146)
32. Pourcyrous M, Korones SB, Yang W, et al. C-reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis. Pediatrics 2005;116:1064-9. (Pubitemid 46056409)
33. Chaaban H, Shin M, Sirya E, et al. Inter- Alpha inhibitor protein level in neonates predicts necrotizing enterocolitis. J Pediatr 2010;157:757-61.
34. Thuijls G, Derikx JP, vanWijck K, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010;251:1174-80.
35. Evennett NJ, Hall NJ, Pierro A, et al. Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg 2010;45:735-40.
36. Reisinger KW, VanderZee DC, Brouwers HA, et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg 2012;47:1640-5.
37. Stone ML, Tatum PM, Weitkamp JH, et al. Abnormal heart rate characteristics before clinical diagnosis of necrotizing enterocolitis. J Perinatol Published Online First: 30 May 2013. doi: 10.1038/jp.2013.63.
38. Ng PC, Ang IL, Chiu RW, et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010;120:2989-3000.